The results of the post-chemotherapy investigation revealed that 3 [3.06% (95% CI 1–8.6)] patients were positive for anti-Toxoplasma IgM and one of them was with new infection of toxoplasmosis in lymphoma patients. The gene discussed is CD40LG; the disease is toxoplasmosis.